{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:14:11Z","timestamp":1791666851690,"version":"4.3.4"},"reference-count":241,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41581-025-00977-8","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T12:04:49Z","timestamp":1752840289000},"page":"671-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Kidney health outcomes of hypertensive disorders of pregnancy"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-4009","authenticated-orcid":false,"given":"Giorgina Barbara","family":"Piccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5561-948X","authenticated-orcid":false,"given":"Massimo","family":"Torreggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Schwotzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranca","family":"Cabiddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Attini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-593X","authenticated-orcid":false,"given":"Alejandra","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0770-8023","authenticated-orcid":false,"given":"Rasha","family":"Shemies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-0761","authenticated-orcid":false,"given":"Shilpanjali","family":"Jesudason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-8002","authenticated-orcid":false,"given":"Fadi","family":"Fakhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-0578","authenticated-orcid":false,"given":"Vesna D.","family":"Garovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"977_CR1","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.3390\/jcm11123420","volume":"11","author":"E Longhitano","year":"2022","unstructured":"Longhitano, E. et al. The hypertensive disorders of pregnancy: a focus on definitions for clinical nephrologists. J. Clin. Med. 11, 3420 (2022).","journal-title":"J. Clin. Med."},{"key":"977_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341\u2013354 (2021).","journal-title":"Lancet"},{"key":"977_CR3","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"LA Magee","year":"2022","unstructured":"Magee, L. A., Nicolaides, K. H. & von Dadelszen, P. Preeclampsia. N. Engl. J. Med. 386, 1817\u20131832 (2022).","journal-title":"N. Engl. J. Med."},{"key":"977_CR4","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","volume":"75","author":"VD Garovic","year":"2020","unstructured":"Garovic, V. D. et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J. Am. Coll. Cardiol. 75, 2323\u20132334 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"977_CR5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0706790","volume":"359","author":"BE Vikse","year":"2008","unstructured":"Vikse, B. E., Irgens, L. M., Leivestad, T., Skjaerven, R. & Iversen, B. M. Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 359, 800\u2013809 (2008).","journal-title":"N. Engl. J. Med."},{"key":"977_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20964","volume":"3","author":"PM Barrett","year":"2020","unstructured":"Barrett, P. M. et al. Adverse pregnancy outcomes and long-term maternal kidney disease: a systematic review and meta-analysis. JAMA Netw. Open 3, e1920964 (2020).","journal-title":"JAMA Netw. Open"},{"key":"977_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.kint.2019.03.033","volume":"96","author":"B Covella","year":"2019","unstructured":"Covella, B. et al. A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia. Kidney Int. 96, 711\u2013727 (2019).","journal-title":"Kidney Int."},{"key":"977_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.kint.2023.04.030","volume":"104","author":"VD Garovic","year":"2023","unstructured":"Garovic, V. D. & Piccoli, G. B. A kidney-centric view of pre-eclampsia through the kidney-placental bidirectional lens. Kidney Int. 104, 213\u2013217 (2023).","journal-title":"Kidney Int."},{"key":"977_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1053\/j.ajkd.2016.07.034","volume":"69","author":"AG Kattah","year":"2017","unstructured":"Kattah, A. G. et al. Preeclampsia and ESRD: the role of shared risk factors. Am. J. Kidney Dis. 69, 498\u2013505 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"977_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/ndt\/gfab225","volume":"37","author":"G Cabiddu","year":"2022","unstructured":"Cabiddu, G. et al. Pre-eclampsia is a valuable opportunity to diagnose chronic kidney disease: a multicentre study. Nephrol. Dial. Transpl. 37, 1488\u20131498 (2022).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40620-017-0444-4","volume":"30","author":"M Ibarra-Hernandez","year":"2017","unstructured":"Ibarra-Hernandez, M. et al. Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from Mexico. J. Nephrol. 30, 773\u2013780 (2017).","journal-title":"J. Nephrol."},{"key":"977_CR12","doi-asserted-by":"publisher","first-page":"624.e1","DOI":"10.1016\/j.ajog.2015.01.009","volume":"212","author":"MF van Oostwaard","year":"2015","unstructured":"van Oostwaard, M. F. et al. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis. Am. J. Obstet. Gynecol. 212, 624.e1\u2013624.e17 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","volume":"9","author":"E Dimitriadis","year":"2023","unstructured":"Dimitriadis, E. et al. Pre-eclampsia. Nat. Rev. Dis. Primers 9, 8 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"977_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40620-017-0390-1","volume":"30","author":"GB Piccoli","year":"2017","unstructured":"Piccoli, G. B. et al. A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J. Nephrol. 30, 307\u2013317 (2017).","journal-title":"J. Nephrol."},{"key":"977_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.kint.2017.11.008","volume":"93","author":"GB Piccoli","year":"2018","unstructured":"Piccoli, G. B. et al. Women and kidney disease: reflections on World Kidney Day 2018. Kidney Int. 93, 278\u2013283 (2018).","journal-title":"Kidney Int."},{"key":"977_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00001648-199903000-00012","volume":"10","author":"KE Innes","year":"1999","unstructured":"Innes, K. E., Marshall, J. A., Byers, T. E. & Calonge, N. A woman\u2019s own birth weight and gestational age predict her later risk of developing preeclampsia, a precursor of chronic disease. Epidemiology 10, 153\u2013160 (1999).","journal-title":"Epidemiology"},{"key":"977_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0140-6736(17)30576-7","volume":"390","author":"VA Luyckx","year":"2017","unstructured":"Luyckx, V. A. et al. A developmental approach to the prevention of hypertension and kidney disease: a report from the low birth weight and nephron number working group. Lancet 390, 424\u2013428 (2017).","journal-title":"Lancet"},{"key":"977_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/HJH.0b013e3282f1a953","volume":"26","author":"CS Homer","year":"2008","unstructured":"Homer, C. S., Brown, M. A., Mangos, G. & Davis, G. K. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J. Hypertens. 26, 295\u2013302 (2008).","journal-title":"J. Hypertens."},{"key":"977_CR19","doi-asserted-by":"crossref","unstructured":"[No authors listed] Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet. Gynecol. 135, e237\u2013e260 (2020).","DOI":"10.1097\/AOG.0000000000003891"},{"key":"977_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee, L. A. et al. The 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management recommendations for international practice. Pregnancy Hypertens. 27, 148\u2013169 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR21","unstructured":"[No authors listed] ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet. Gynecol. 133, 1 (2019)."},{"key":"977_CR22","unstructured":"Society of Obstetric Medicine of Australia and New Zealand. Hypertension in Pregnancy Guideline 2023 (SOMANZ, 2024)."},{"key":"977_CR23","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41440-022-00965-6","volume":"45","author":"H Metoki","year":"2022","unstructured":"Metoki, H. et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens. Res. 45, 1298\u20131309 (2022).","journal-title":"Hypertens. Res."},{"key":"977_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","volume":"27","author":"S Verlohren","year":"2022","unstructured":"Verlohren, S. et al. Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 27, 42\u201350 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ki.2012.348","volume":"83","author":"A Rolfo","year":"2013","unstructured":"Rolfo, A. et al. Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int. 83, 177\u2013181 (2013).","journal-title":"Kidney Int."},{"key":"977_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40620-016-0285-6","volume":"29","author":"G Cabiddu","year":"2016","unstructured":"Cabiddu, G. et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J. Nephrol. 29, 277\u2013303 (2016).","journal-title":"J. Nephrol."},{"key":"977_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12882-019-1560-2","volume":"20","author":"K Wiles","year":"2019","unstructured":"Wiles, K. et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 20, 401 (2019).","journal-title":"BMC Nephrol."},{"key":"977_CR28","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.3390\/ijms24043752","volume":"24","author":"J Modzelewski","year":"2023","unstructured":"Modzelewski, J. et al. Atypical preeclampsia before 20 weeks of gestation \u2014 a systematic review. Int. J. Mol. Sci. 24, 3752 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"977_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee, L. A. et al. Less-tight versus tight control of hypertension in pregnancy. N. Engl. J. Med. 372, 407\u2013417 (2015).","journal-title":"N. Engl. J. Med."},{"key":"977_CR30","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","volume":"386","author":"AT Tita","year":"2022","unstructured":"Tita, A. T. et al. Treatment for mild chronic hypertension during pregnancy. N. Engl. J. Med. 386, 1781\u20131792 (2022).","journal-title":"N. Engl. J. Med."},{"key":"977_CR31","doi-asserted-by":"publisher","first-page":"468.e1","DOI":"10.1016\/j.ajog.2013.02.015","volume":"208","author":"J Brewer","year":"2013","unstructured":"Brewer, J. et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am. J. Obstet. Gynecol. 208, 468.e1\u2013468.e6 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey, J. et al. A reversible posterior leukoencephalopathy syndrome. N. Engl. J. Med. 334, 494\u2013500 (1996).","journal-title":"N. Engl. J. Med."},{"key":"977_CR33","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","volume":"79","author":"VD Garovic","year":"2022","unstructured":"Garovic, V. D. et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension 79, e21\u2013e41 (2022).","journal-title":"Hypertension"},{"key":"977_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34858","volume":"6","author":"J Santos","year":"2023","unstructured":"Santos, J., Schenone, M. H. & Garovic, V. D. Early identification of individuals at risk for hypertensive disorders of pregnancy. JAMA Netw. Open 6, e2334858 (2023).","journal-title":"JAMA Netw. Open"},{"key":"977_CR35","doi-asserted-by":"publisher","first-page":"f6564","DOI":"10.1136\/bmj.f6564","volume":"347","author":"CV Ananth","year":"2013","unstructured":"Ananth, C. V., Keyes, K. M. & Wapner, R. J. Pre-eclampsia rates in the United States, 1980\u20132010: age-period-cohort analysis. BMJ 347, f6564 (2013).","journal-title":"BMJ"},{"key":"977_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM199707103370201","volume":"337","author":"RJ Levine","year":"1997","unstructured":"Levine, R. J. et al. Trial of calcium to prevent preeclampsia. N. Engl. J. Med. 337, 69\u201376 (1997).","journal-title":"N. Engl. J. Med."},{"key":"977_CR37","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say, L. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health 2, e323\u2013e333 (2014).","journal-title":"Lancet Glob. Health"},{"key":"977_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03809-2","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth 21, 364 (2021).","journal-title":"BMC Pregnancy Childbirth"},{"key":"977_CR39","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello, A. K. et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob. Health 12, e382\u2013e395 (2024).","journal-title":"Lancet Glob. Health"},{"key":"977_CR40","volume":"28","author":"DS Lopez","year":"2023","unstructured":"Lopez, D. S., Hernandez Vargas, J. A., Urina-Jassir, M., Urina-Triana, M. & Franco, O. H. Reducing the gap of chronic kidney disease in low- and middle-income countries: what is missing? Lancet Reg. Health Am. 28, 100625 (2023).","journal-title":"Lancet Reg. Health Am."},{"key":"977_CR41","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/ndt\/gfv466","volume":"31","author":"JW Stanifer","year":"2016","unstructured":"Stanifer, J. W., Muiru, A., Jafar, T. H. & Patel, U. D. Chronic kidney disease in low- and middle-income countries. Nephrol. Dial. Transpl. 31, 868\u2013874 (2016).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR42","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1093\/ckj\/sfab055","volume":"14","author":"M Torreggiani","year":"2021","unstructured":"Torreggiani, M. et al. Unmet needs for CKD care: from the general population to the CKD clinics \u2014 how many patients are we missing? Clin. Kidney J. 14, 2246\u20132254 (2021).","journal-title":"Clin. Kidney J."},{"key":"977_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/bmj.39406.652986.BE","volume":"336","author":"D Williams","year":"2008","unstructured":"Williams, D. & Davison, J. Chronic kidney disease in pregnancy. BMJ 336, 211\u2013215 (2008).","journal-title":"BMJ"},{"key":"977_CR44","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s40620-022-01546-z","volume":"36","author":"WAL Vrijlandt","year":"2023","unstructured":"Vrijlandt, W. A. L. et al. Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J. Nephrol. 36, 1341\u20131347 (2023).","journal-title":"J. Nephrol."},{"key":"977_CR45","unstructured":"United Nations Department of Economic and Social Affairs. World Population Prospects 2022: Summary of Results (UNDESA, 2022)."},{"key":"977_CR46","unstructured":"World Health Organization. Trends in Maternal Mortality 2000 to 2020: Estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA\/Population Division (WHO, 2023)."},{"key":"977_CR47","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42343","volume":"5","author":"SM Wheeler","year":"2022","unstructured":"Wheeler, S. M., Myers, S. O., Swamy, G. K. & Myers, E. R. Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019. JAMA Netw. Open 5, e2142343 (2022).","journal-title":"JAMA Netw. Open"},{"key":"977_CR48","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2215\/CJN.07830520","volume":"16","author":"M Hannan","year":"2021","unstructured":"Hannan, M. et al. Risk factors for CKD progression: overview of findings from the CRIC study. Clin. J. Am. Soc. Nephrol. 16, 648\u2013659 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"977_CR49","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mayocp.2024.04.002","volume":"99","author":"D Dilmaghani","year":"2024","unstructured":"Dilmaghani, D., Nath, K. A. & Garovic, V. D. Increasing maternal mortality in the United States: looking beneath and beyond the numbers. Mayo Clin. Proc. 99, 873\u2013877 (2024).","journal-title":"Mayo Clin. Proc."},{"key":"977_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/imj.13669","volume":"48","author":"AL Daly","year":"2018","unstructured":"Daly, A. L. et al. Risk factors associated with hypertensive disorders of pregnancy within an urban indigenous population in south western Sydney. Intern. Med. J. 48, 269\u2013275 (2018).","journal-title":"Intern. Med. J."},{"key":"977_CR51","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/jan.15493","volume":"79","author":"C Austin","year":"2023","unstructured":"Austin, C. The impact of social determinants of health of Australian indigenous women on access and engagement in maternal child health services. J. Adv. Nurs. 79, 1815\u20131829 (2023).","journal-title":"J. Adv. Nurs."},{"key":"977_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-020-1155-3","volume":"19","author":"S Kendall","year":"2020","unstructured":"Kendall, S., Lighton, S., Sherwood, J., Baldry, E. & Sullivan, E. A. Incarcerated aboriginal women\u2019s experiences of accessing healthcare and the limitations of the \u2018equal treatment\u2019 principle. Int. J. Equity Health 19, 48 (2020).","journal-title":"Int. J. Equity Health"},{"key":"977_CR53","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/sj.ki.5000397","volume":"70","author":"WE Hoy","year":"2006","unstructured":"Hoy, W. E., Hughson, M. D., Singh, G. R., Douglas-Denton, R. & Bertram, J. F. Reduced nephron number and glomerulomegaly in Australian aborigines: a group at high risk for renal disease and hypertension. Kidney Int. 70, 104\u2013110 (2006).","journal-title":"Kidney Int."},{"key":"977_CR54","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/nep.12798","volume":"21","author":"WE Hoy","year":"2016","unstructured":"Hoy, W. E., Mott, S. A. & Mc Donald, S. P. An expanded nationwide view of chronic kidney disease in aboriginal Australians. Nephrology 21, 916\u2013922 (2016).","journal-title":"Nephrology"},{"key":"977_CR55","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1907859","volume":"381","author":"C Sorensen","year":"2019","unstructured":"Sorensen, C. & Garcia-Trabanino, R. A new era of climate medicine \u2014 addressing heat-triggered renal disease. N. Engl. J. Med. 381, 693\u2013696 (2019).","journal-title":"N. Engl. J. Med."},{"key":"977_CR56","doi-asserted-by":"publisher","first-page":"52279","DOI":"10.1007\/s11356-024-34689-6","volume":"31","author":"AT Gebremedhin","year":"2024","unstructured":"Gebremedhin, A. T., Nyadanu, S. D., Hanigan, I. C. & Pereira, G. Maternal exposure to bioclimatic stress and hypertensive disorders of pregnancy in Western Australia: identifying potential critical windows of susceptibility. Env. Sci. Pollut. Res. Int. 31, 52279\u201352292 (2024).","journal-title":"Env. Sci. Pollut. Res. Int."},{"key":"977_CR57","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/tmi.13913","volume":"28","author":"IR Rao","year":"2023","unstructured":"Rao, I. R. et al. Chronic kidney disease of unknown aetiology: a comprehensive review of a global public health problem. Trop. Med. Int. Health 28, 588\u2013600 (2023).","journal-title":"Trop. Med. Int. Health"},{"key":"977_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108715","volume":"9","author":"AE Khan","year":"2014","unstructured":"Khan, A. E. et al. Salinity in drinking water and the risk of (pre)eclampsia and gestational hypertension in coastal Bangladesh: a case-control study. PLoS ONE 9, e108715 (2014).","journal-title":"PLoS ONE"},{"key":"977_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284126","volume":"18","author":"R Mondal","year":"2023","unstructured":"Mondal, R., Banik, P. C., Faruque, M., Mashreky, S. R. & Ali, L. Association of exposure to salinity in groundwater with chronic kidney disease among diabetic population in Bangladesh. PLoS ONE 18, e0284126 (2023).","journal-title":"PLoS ONE"},{"key":"977_CR60","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1161\/HYPERTENSIONAHA.116.07743","volume":"68","author":"PF Scheelbeek","year":"2016","unstructured":"Scheelbeek, P. F., Khan, A. E., Mojumder, S., Elliott, P. & Vineis, P. Drinking water sodium and elevated blood pressure of healthy pregnant women in salinity-affected coastal areas. Hypertension 68, 464\u2013470 (2016).","journal-title":"Hypertension"},{"key":"977_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.preghy.2021.12.002","volume":"27","author":"M Demissie","year":"2022","unstructured":"Demissie, M., Molla, G., Tayachew, A. & Getachew, F. Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study. Pregnancy Hypertens. 27, 36\u201341 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.preghy.2023.07.177","volume":"33","author":"TK Beyuo","year":"2023","unstructured":"Beyuo, T. K. et al. Impact of antenatal care on severe maternal and neonatal outcomes in pregnancies complicated by preeclampsia and eclampsia in Ghana. Pregnancy Hypertens. 33, 46\u201351 (2023).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR63","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40620-017-0428-4","volume":"30","author":"J Nava","year":"2017","unstructured":"Nava, J. et al. Successful pregnancy in a CKD patient on a low-protein, supplemented diet: an opportunity to reflect on CKD and pregnancy in Mexico, an emerging country. J. Nephrol. 30, 877\u2013882 (2017).","journal-title":"J. Nephrol."},{"key":"977_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000511539","volume":"46","author":"AO Orozco-Guillien","year":"2021","unstructured":"Orozco-Guillien, A. O. et al. Quality or quantity of proteins in the diet for CKD patients: does \u201cJunk Food\u201d make a difference? lessons from a high-risk pregnancy. Kidney Blood Press. Res. 46, 1\u201310 (2021).","journal-title":"Kidney Blood Press. Res."},{"key":"977_CR65","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jamacardio.2023.1312","volume":"8","author":"JS Tyrmi","year":"2023","unstructured":"Tyrmi, J. S. et al. Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy. JAMA Cardiol. 8, 674\u2013683 (2023).","journal-title":"JAMA Cardiol."},{"key":"977_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ajhg.2018.08.002","volume":"103","author":"KJ Reidy","year":"2018","unstructured":"Reidy, K. J. et al. Fetal-not maternal-APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am. J. Hum. Genet. 103, 367\u2013376 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"977_CR67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0031-1285097","volume":"29","author":"D Dizon-Townson","year":"2012","unstructured":"Dizon-Townson, D. et al. Impact of smoking during pregnancy on functional coagulation testing. Am. J. Perinatol. 29, 225\u2013230 (2012).","journal-title":"Am. J. Perinatol."},{"key":"977_CR68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/molehr\/gas041","volume":"19","author":"DA Loisel","year":"2013","unstructured":"Loisel, D. A. et al. The maternal HLA-G 1597\u0394C null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women. Mol. Hum. Reprod. 19, 144\u2013152 (2013).","journal-title":"Mol. Hum. Reprod."},{"key":"977_CR69","doi-asserted-by":"publisher","first-page":"e1291","DOI":"10.1055\/a-2008-7167","volume":"41","author":"MB Conklin","year":"2024","unstructured":"Conklin, M. B. et al. Understanding health disparities in preeclampsia: a literature review. Am. J. Perinatol. 41, e1291\u2013e1300 (2024).","journal-title":"Am. J. Perinatol."},{"key":"977_CR70","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672\u2013683 (2004).","journal-title":"N. Engl. J. Med."},{"key":"977_CR71","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649\u2013658 (2003).","journal-title":"J. Clin. Invest."},{"key":"977_CR72","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200161","volume":"1","author":"R Thadhani","year":"2022","unstructured":"Thadhani, R. et al. Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM Evid. 1, EVIDoa2200161 (2022).","journal-title":"NEJM Evid."},{"key":"977_CR73","unstructured":"US Food and Drug Administration. FDA roundup: May 19, 2023. FDA https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-roundup-may-19-2023 (2023)."},{"key":"977_CR74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158346","volume":"132","author":"V Dupont","year":"2022","unstructured":"Dupont, V. et al. Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway. J. Clin. Invest. 132, e158346 (2022).","journal-title":"J. Clin. Invest."},{"key":"977_CR75","doi-asserted-by":"publisher","first-page":"11545","DOI":"10.3390\/ijerph182111545","volume":"18","author":"M Broekhuizen","year":"2021","unstructured":"Broekhuizen, M., Danser, A. H. J., Reiss, I. K. M. & Merkus, D. The function of the kynurenine pathway in the placenta: a novel pharmacotherapeutic target? Int. J. Environ. Res. Public Health 18, 11545 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"977_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.101203","volume":"5","author":"S Yagel","year":"2023","unstructured":"Yagel, S. et al. Expert review: preeclampsia type I and type II. Am. J. Obstet. Gynecol. MFM 5, 101203 (2023).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"977_CR77","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes Working Group.","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes Working Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"977_CR78","doi-asserted-by":"publisher","first-page":"320.e1","DOI":"10.1016\/j.ajog.2007.02.007","volume":"196","author":"VD Garovic","year":"2007","unstructured":"Garovic, V. D. et al. Urinary podocyte excretion as a marker for preeclampsia. Am. J. Obstet. Gynecol. 196, 320.e1\u2013320.e7 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/984630","volume":"2012","author":"B Jim","year":"2012","unstructured":"Jim, B. et al. Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients. J. Pregnancy 2012, 984630 (2012).","journal-title":"J. Pregnancy"},{"key":"977_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101445","volume":"9","author":"B Jim","year":"2014","unstructured":"Jim, B. et al. A comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study. PLoS ONE 9, e101445 (2014).","journal-title":"PLoS ONE"},{"key":"977_CR81","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00000441-200008000-00009","volume":"320","author":"T Nakamura","year":"2000","unstructured":"Nakamura, T. et al. Urinary podocytes for the assessment of disease activity in lupus nephritis. Am. J. Med. Sci. 320, 112\u2013116 (2000).","journal-title":"Am. J. Med. Sci."},{"key":"977_CR82","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00005792-198107000-00002","volume":"60","author":"KA Fisher","year":"1981","unstructured":"Fisher, K. A., Luger, A., Spargo, B. H. & Lindheimer, M. D. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine 60, 267\u2013276 (1981).","journal-title":"Medicine"},{"key":"977_CR83","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1681\/ASN.2016111202","volume":"28","author":"SI Gilani","year":"2017","unstructured":"Gilani, S. I. et al. Urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia. J. Am. Soc. Nephrol. 28, 3363\u20133372 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"977_CR84","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/HYPERTENSIONAHA.115.06554","volume":"67","author":"TL Weissgerber","year":"2016","unstructured":"Weissgerber, T. L., Milic, N. M., Milin-Lazovic, J. S. & Garovic, V. D. Impaired flow-mediated dilation before, during, and after preeclampsia: a systematic review and meta-analysis. Hypertension 67, 415\u2013423 (2016).","journal-title":"Hypertension"},{"key":"977_CR85","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1093\/ndt\/gfq169","volume":"25","author":"BE Vikse","year":"2010","unstructured":"Vikse, B. E., Hallan, S., Bostad, L., Leivestad, T. & Iversen, B. M. Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol. Dial. Transpl. 25, 3289\u20133296 (2010).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR86","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ekir.2018.10.012","volume":"4","author":"AL Oliverio","year":"2019","unstructured":"Oliverio, A. L. et al. Renal complications in pregnancy preceding glomerulonephropathy diagnosis. Kidney Int. Rep. 4, 159\u2013162 (2019).","journal-title":"Kidney Int. Rep."},{"key":"977_CR87","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ekir.2021.12.014","volume":"7","author":"G Cabiddu","year":"2022","unstructured":"Cabiddu, G. et al. History of preeclampsia in patients undergoing a kidney biopsy: a biphasic, multiple-hit pathogenic hypothesis. Kidney Int. Rep. 7, 547\u2013557 (2022).","journal-title":"Kidney Int. Rep."},{"key":"977_CR88","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/HYPERTENSIONAHA.119.13089","volume":"74","author":"FI Conti-Ramsden","year":"2019","unstructured":"Conti-Ramsden, F. I. et al. Pregnancy-related acute kidney injury in preeclampsia: risk factors and renal outcomes. Hypertension 74, 1144\u20131151 (2019).","journal-title":"Hypertension"},{"key":"977_CR89","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0950-3552(05)80330-X","volume":"8","author":"LW Gaber","year":"1994","unstructured":"Gaber, L. W., Spargo, B. H. & Lindheimer, M. D. Renal pathology in pre-eclampsia. Baillieres Clin. Obstet. Gynaecol. 8, 443\u2013468 (1994).","journal-title":"Baillieres Clin. Obstet. Gynaecol."},{"key":"977_CR90","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0272-6386(12)81119-X","volume":"17","author":"P Kincaid-Smith","year":"1991","unstructured":"Kincaid-Smith, P. The renal lesion of preeclampsia revisited. Am. J. Kidney Dis. 17, 144\u2013148 (1991).","journal-title":"Am. J. Kidney Dis."},{"key":"977_CR91","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1681\/ASN.2007020255","volume":"18","author":"IE Stillman","year":"2007","unstructured":"Stillman, I. E. & Karumanchi, S. A. The glomerular injury of preeclampsia. J. Am. Soc. Nephrol. 18, 2281\u20132284 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"977_CR92","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/ndt\/gfz025","volume":"35","author":"F Meibody","year":"2020","unstructured":"Meibody, F. et al. Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers. Nephrol. Dial. Transpl. 35, 1538\u20131546 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR93","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40620-018-0488-0","volume":"31","author":"P Villie","year":"2018","unstructured":"Villie, P. et al. Why kidneys fail post-partum: a tubulocentric viewpoint. J. Nephrol. 31, 645\u2013651 (2018).","journal-title":"J. Nephrol."},{"key":"977_CR94","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.3390\/jcm10235629","volume":"10","author":"P Rodriguez-Benitez","year":"2021","unstructured":"Rodriguez-Benitez, P. et al. Maternal-perinatal variables in patients with severe preeclampsia who develop acute kidney injury. J. Clin. Med. 10, 5629 (2021).","journal-title":"J. Clin. Med."},{"key":"977_CR95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5005\/japi-11001-0110","volume":"70","author":"M Sahay","year":"2022","unstructured":"Sahay, M., Dogra, L., Ismal, K. & Vali, S. Pregnancy-related acute kidney injury in public hospital in South India: changing trends. J. Assoc. Physicians India 70, 11\u201312 (2022).","journal-title":"J. Assoc. Physicians India"},{"key":"977_CR96","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029563","volume":"101","author":"T Trakarnvanich","year":"2022","unstructured":"Trakarnvanich, T., Ngamvichchukorn, T. & Susantitaphong, P. Incidence of acute kidney injury during pregnancy and its prognostic value for adverse clinical outcomes: a systematic review and meta-analysis. Medicine 101, e29563 (2022).","journal-title":"Medicine"},{"key":"977_CR97","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s40620-022-01349-2","volume":"35","author":"AS Shalaby","year":"2022","unstructured":"Shalaby, A. S. & Shemies, R. S. Pregnancy-related acute kidney injury in the African continent: where do we stand? A systematic review. J. Nephrol. 35, 2175\u20132189 (2022).","journal-title":"J. Nephrol."},{"key":"977_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/1319-2442.198092","volume":"28","author":"Z Karimi","year":"2017","unstructured":"Karimi, Z., Malekmakan, L. & Farshadi, M. The prevalence of pregnancy-related acute renal failure in Asia: a systematic review. Saudi J. Kidney Dis. Transpl. 28, 1\u20138 (2017).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"977_CR99","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/08860220600583658","volume":"28","author":"J Prakash","year":"2006","unstructured":"Prakash, J. et al. Acute renal failure in pregnancy in a developing country: twenty years of experience. Ren. Fail. 28, 309\u2013313 (2006).","journal-title":"Ren. Fail."},{"key":"977_CR100","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12882-024-03616-9","volume":"25","author":"E Berhe","year":"2024","unstructured":"Berhe, E. et al. Characteristics and outcome of pregnancy-related acute kidney injury in a teaching hospital in a low-resource setting: a five-year retrospective review. BMC Nephrol. 25, 182 (2024).","journal-title":"BMC Nephrol."},{"key":"977_CR101","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000505894","volume":"51","author":"S Shah","year":"2020","unstructured":"Shah, S. et al. Pregnancy-related acute kidney injury in the United States: clinical outcomes and health care utilization. Am. J. Nephrol. 51, 216\u2013226 (2020).","journal-title":"Am. J. Nephrol."},{"key":"977_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237600","volume":"15","author":"MW Meazaw","year":"2020","unstructured":"Meazaw, M. W., Chojenta, C., Muluneh, M. D. & Loxton, D. Systematic and meta-analysis of factors associated with preeclampsia and eclampsia in sub-Saharan Africa. PLoS ONE 15, e0237600 (2020).","journal-title":"PLoS ONE"},{"key":"977_CR103","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s40620-019-00629-8","volume":"32","author":"Z Filali Khattabi","year":"2019","unstructured":"Filali Khattabi, Z. et al. Chronic kidney disease in preeclamptic patients: not found unless searched for-is a nephrology evaluation useful after an episode of preeclampsia? J. Nephrol. 32, 977\u2013987 (2019).","journal-title":"J. Nephrol."},{"key":"977_CR104","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000499964","volume":"49","author":"M Ibarra-Hernandez","year":"2019","unstructured":"Ibarra-Hernandez, M. et al. Challenges in managing pregnancy in underserved women with chronic kidney disease. Am. J. Nephrol. 49, 386\u2013396 (2019).","journal-title":"Am. J. Nephrol."},{"key":"977_CR105","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bpobgyn.2018.12.005","volume":"57","author":"DR Hall","year":"2019","unstructured":"Hall, D. R. & Conti-Ramsden, F. Acute kidney injury in pregnancy including renal disease diagnosed in pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 57, 47\u201359 (2019).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"977_CR106","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.preghy.2017.11.008","volume":"12","author":"TA Facca","year":"2018","unstructured":"Facca, T. A. et al. Pregnancy as an early stress test for cardiovascular and kidney disease diagnosis. Pregnancy Hypertens. 12, 169\u2013173 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR107","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s13224-017-1055-7","volume":"68","author":"A Kaul","year":"2018","unstructured":"Kaul, A. et al. Pregnancy check point for diagnosis of CKD in developing countries. J. Obstet. Gynaecol. India 68, 440\u2013446 (2018).","journal-title":"J. Obstet. Gynaecol. India"},{"key":"977_CR108","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/jcm8040475","volume":"8","author":"JCH Rivera","year":"2019","unstructured":"Rivera, J. C. H. et al. Delayed initiation of hemodialysis in pregnant women with chronic kidney disease: logistical problems impact clinical outcomes. an experience from an emerging country. J. Clin. Med. 8, 475 (2019).","journal-title":"J. Clin. Med."},{"key":"977_CR109","unstructured":"National Institute for Health Care and Excellence. Hypertension in Pregnancy: Follow-up Care and Postnatal Review (NICE, 2023)."},{"key":"977_CR110","unstructured":"National Institute for Health Care and Excellence. Hypertension in Pregnancy: Diagnosis and Management (NICE, 2023)."},{"key":"977_CR111","volume":"18","author":"NA Smart","year":"2014","unstructured":"Smart, N. A., Dieberg, G., Ladhani, M. & Titus, T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst. Rev. 18, CD007333 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"977_CR112","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1093\/ndt\/gfh409","volume":"19","author":"RM Huisman","year":"2004","unstructured":"Huisman, R. M. The deadly risk of late referral. Nephrol. Dial. Transpl. 19, 2175\u20132180 (2004).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR113","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ajog.2021.10.037","volume":"226","author":"S Al Khalaf","year":"2022","unstructured":"Al Khalaf, S. et al. Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 226, 656\u2013670.e32 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR114","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/1471-0528.17807","volume":"131","author":"D Jeyaraman","year":"2024","unstructured":"Jeyaraman, D. et al. Adverse pregnancy outcomes in pregnant women with chronic kidney disease: a systematic review and meta-analysis. BJOG 131, 1331\u20131340 (2024).","journal-title":"BJOG"},{"key":"977_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.100928","volume":"5","author":"S Marek-Iannucci","year":"2023","unstructured":"Marek-Iannucci, S. et al. Association of chronic kidney dysfunction and preeclampsia: insights of the nationwide inpatient sample. Am. J. Obstet. Gynecol. MFM 5, 100928 (2023).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"977_CR116","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.kint.2023.12.018","volume":"105","author":"GB Piccoli","year":"2024","unstructured":"Piccoli, G. B. et al. Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome. Kidney Int. 105, 865\u2013876 (2024).","journal-title":"Kidney Int."},{"key":"977_CR117","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1681\/ASN.2014050459","volume":"26","author":"GB Piccoli","year":"2015","unstructured":"Piccoli, G. B. et al. Risk of adverse pregnancy outcomes in women with CKD. J. Am. Soc. Nephrol. 26, 2011\u20132022 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"977_CR118","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2215\/CJN.12171017","volume":"13","author":"JS Tangren","year":"2018","unstructured":"Tangren, J. S. et al. Metabolic and hypertensive complications of pregnancy in women with nephrolithiasis. Clin. J. Am. Soc. Nephrol. 13, 612\u2013619 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"977_CR119","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1681\/ASN.2016070806","volume":"28","author":"JS Tangren","year":"2017","unstructured":"Tangren, J. S. et al. Pregnancy outcomes after clinical recovery from AKI. J. Am. Soc. Nephrol. 28, 1566\u20131574 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"977_CR120","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/HYPERTENSIONAHA.118.11161","volume":"72","author":"JS Tangren","year":"2018","unstructured":"Tangren, J. S. et al. Risk of preeclampsia and pregnancy complications in women with a history of acute kidney injury. Hypertension 72, 451\u2013459 (2018).","journal-title":"Hypertension"},{"key":"977_CR121","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1111\/ajt.17122","volume":"22","author":"M Pippias","year":"2022","unstructured":"Pippias, M. et al. Pregnancy after living kidney donation, a systematic review of the available evidence, and a review of the current guidance. Am. J. Transpl. 22, 2360\u20132380 (2022).","journal-title":"Am. J. Transpl."},{"key":"977_CR122","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.preghy.2022.06.005","volume":"29","author":"Y He","year":"2022","unstructured":"He, Y. et al. Pregnancy in patients with stage 3\u20135 CKD: maternal and fetal outcomes. Pregnancy Hypertens. 29, 86\u201391 (2022).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR123","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/ndt\/gfaa247","volume":"36","author":"K Wiles","year":"2021","unstructured":"Wiles, K. et al. The impact of chronic kidney disease Stages 3\u20135 on pregnancy outcomes. Nephrol. Dial. Transpl. 36, 2008\u20132017 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR124","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1053\/j.ajkd.2007.03.022","volume":"49","author":"E Imbasciati","year":"2007","unstructured":"Imbasciati, E. et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am. J. Kidney Dis. 49, 753\u2013762 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"977_CR125","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ekir.2019.04.005","volume":"4","author":"GB Piccoli","year":"2019","unstructured":"Piccoli, G. B. What is superimposed preeclampsia (and does it actually exist)? Kidney Int. Rep. 4, 759\u2013762 (2019).","journal-title":"Kidney Int. Rep."},{"key":"977_CR126","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preghy.2021.02.010","volume":"24","author":"K Wiles","year":"2021","unstructured":"Wiles, K. et al. Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens. 24, 58\u201364 (2021).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR127","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/10641955.2020.1769643","volume":"39","author":"K Bramham","year":"2020","unstructured":"Bramham, K. et al. Predisposition to superimposed preeclampsia in women with chronic hypertension: endothelial, renal, cardiac, and placental factors in a prospective longitudinal cohort. Hypertens. Pregnancy 39, 326\u2013335 (2020).","journal-title":"Hypertens. Pregnancy"},{"key":"977_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s40697-016-0096-7","volume":"3","author":"A Akbari","year":"2016","unstructured":"Akbari, A. et al. Circulating angiogenic factors in a pregnant woman on intensive hemodialysis: a case report. Can. J. Kidney Health Dis. 3, 7 (2016).","journal-title":"Can. J. Kidney Health Dis."},{"key":"977_CR129","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.ekir.2021.02.029","volume":"6","author":"R Shanmugalingam","year":"2021","unstructured":"Shanmugalingam, R., Cole-Clark, A., Lowrie, E., Hennessy, A. & Makris, A. Clinical use of angiogenic factors in managing a pregnant woman on hemodialysis to term. Kidney Int. Rep. 6, 1449\u20131453 (2021).","journal-title":"Kidney Int. Rep."},{"key":"977_CR130","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13730-019-00435-y","volume":"9","author":"H Morisawa","year":"2020","unstructured":"Morisawa, H. et al. Difficulty of predicting early-onset super-imposed preeclampsia in pregnant women with hemodialysis due to diabetic nephropathy by serum levels of sFlt-1, PlGF, and sEng. CEN Case Rep. 9, 101\u2013105 (2020).","journal-title":"CEN Case Rep."},{"key":"977_CR131","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.kint.2022.06.006","volume":"102","author":"ME Gosselink","year":"2022","unstructured":"Gosselink, M. E. et al. A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes. Kidney Int. 102, 866\u2013875 (2022).","journal-title":"Kidney Int."},{"key":"977_CR132","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ekir.2022.03.015","volume":"7","author":"E Hewawasam","year":"2022","unstructured":"Hewawasam, E. et al. Determinants of perinatal outcomes in dialyzed and transplanted women in Australia. Kidney Int. Rep. 7, 1318\u20131331 (2022).","journal-title":"Kidney Int. Rep."},{"key":"977_CR133","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12882-019-1213-5","volume":"20","author":"S Shah","year":"2019","unstructured":"Shah, S. et al. Pregnancy outcomes in women with kidney transplant: metaanalysis and systematic review. BMC Nephrol. 20, 24 (2019).","journal-title":"BMC Nephrol."},{"key":"977_CR134","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2215\/CJN.0000000000000155","volume":"18","author":"J Lu","year":"2023","unstructured":"Lu, J. et al. Preeclampsia after kidney transplantation: rates and association with graft survival and function. Clin. J. Am. Soc. Nephrol. 18, 920\u2013929 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"977_CR135","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/10641955.2020.1801717","volume":"39","author":"V Dines","year":"2020","unstructured":"Dines, V., D\u2019Costa, M., Fidler, M. & Kattah, A. The role of kidney biopsy in diagnosis of preeclampsia in kidney transplant patients. Hypertens. Pregnancy 39, 418\u2013422 (2020).","journal-title":"Hypertens. Pregnancy"},{"key":"977_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173420","volume":"12","author":"GB Majak","year":"2017","unstructured":"Majak, G. B. et al. Preeclampsia in kidney transplanted women; outcomes and a simple prognostic risk score system. PLoS ONE 12, e0173420 (2017).","journal-title":"PLoS ONE"},{"key":"977_CR137","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/AOG.0000000000002404","volume":"131","author":"V Vannevel","year":"2018","unstructured":"Vannevel, V. et al. Preeclampsia and long-term renal function in women who underwent kidney transplantation. Obstet. Gynecol. 131, 57\u201362 (2018).","journal-title":"Obstet. Gynecol."},{"key":"977_CR138","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/ndt\/gfx061","volume":"33","author":"S Park","year":"2018","unstructured":"Park, S. et al. Pregnancy in women with immunoglobulin A nephropathy: are obstetrical complications associated with renal prognosis? Nephrol. Dial. Transpl. 33, 459\u2013465 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR139","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/ar.24270","volume":"303","author":"VA Luyckx","year":"2020","unstructured":"Luyckx, V. A. & Brenner, B. M. Clinical consequences of developmental programming of low nephron number. Anat. Rec. 303, 2613\u20132631 (2020).","journal-title":"Anat. Rec."},{"key":"977_CR140","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preghy.2021.03.001","volume":"24","author":"F Li","year":"2021","unstructured":"Li, F. et al. Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: a meta-analysis of cohort studies. Pregnancy Hypertens. 24, 107\u2013117 (2021).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR141","doi-asserted-by":"publisher","first-page":"269.e1","DOI":"10.1016\/j.ajog.2009.06.060","volume":"201","author":"CS Wu","year":"2009","unstructured":"Wu, C. S. et al. Health of children born to mothers who had preeclampsia: a population-based cohort study. Am. J. Obstet. Gynecol. 201, 269.e1\u2013269.e10 (2009).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR142","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/children10050826","volume":"10","author":"S Koulouraki","year":"2023","unstructured":"Koulouraki, S. et al. Short- and long-term outcomes of preeclampsia in offspring: review of the literature. Children 10, 826 (2023).","journal-title":"Children"},{"key":"977_CR143","doi-asserted-by":"publisher","first-page":"F1315","DOI":"10.1152\/ajprenal.00071.2020","volume":"318","author":"HR Turbeville","year":"2020","unstructured":"Turbeville, H. R. & Sasser, J. M. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am. J. Physiol. Renal Physiol. 318, F1315\u2013F1326 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"977_CR144","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbr.2016.01.030","volume":"302","author":"MT Ratsep","year":"2016","unstructured":"Ratsep, M. T. et al. Impact of preeclampsia on cognitive function in the offspring. Behav. Brain Res. 302, 175\u2013181 (2016).","journal-title":"Behav. Brain Res."},{"key":"977_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02070-5","volume":"29","author":"E Kokori","year":"2024","unstructured":"Kokori, E. et al. Maternal and fetal neurocognitive outcomes in preeclampsia and eclampsia; a narrative review of current evidence. Eur. J. Med. Res. 29, 470 (2024).","journal-title":"Eur. J. Med. Res."},{"key":"977_CR146","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.earlhumdev.2016.09.007","volume":"102","author":"A Bokslag","year":"2016","unstructured":"Bokslag, A., van Weissenbruch, M., Mol, B. W. & de Groot, C. J. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum. Dev. 102, 47\u201350 (2016).","journal-title":"Early Hum. Dev."},{"key":"977_CR147","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell, L. C. et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet 394, 1181\u20131190 (2019).","journal-title":"Lancet"},{"key":"977_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.936560","volume":"9","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Aspirin for the prevention of preeclampsia: a systematic review and meta-analysis of randomized controlled studies. Front. Cardiovasc. Med. 9, 936560 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"977_CR149","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","volume":"216","author":"S Roberge","year":"2017","unstructured":"Roberge, S. et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 216, 110\u2013120 e116 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR150","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1479-828X.1995.tb02141.x","volume":"35","author":"RA North","year":"1995","unstructured":"North, R. A., Ferrier, C., Gamble, G., Fairley, K. F. & Kincaid-Smith, P. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust. N. Z. J. Obstet. Gynaecol. 35, 357\u2013362 (1995).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"977_CR151","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","volume":"10","author":"JI de Vries","year":"2012","unstructured":"de Vries, J. I. et al. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J. Thromb. Haemost. 10, 64\u201372 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"977_CR152","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","volume":"197","author":"ME van Hoorn","year":"2016","unstructured":"van Hoorn, M. E. et al. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT. Eur. J. Obstet. Gynecol. Reprod. Biol. 197, 168\u2013173 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"977_CR153","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","volume":"119","author":"I Martinelli","year":"2012","unstructured":"Martinelli, I. et al. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood 119, 3269\u20133275 (2012).","journal-title":"Blood"},{"key":"977_CR154","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","volume":"128","author":"B Haddad","year":"2016","unstructured":"Haddad, B. et al. Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial. Obstet. Gynecol. 128, 1053\u20131063 (2016).","journal-title":"Obstet. Gynecol."},{"key":"977_CR155","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1080\/14767058.2018.1543656","volume":"33","author":"X Wang","year":"2020","unstructured":"Wang, X. & Gao, H. Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis. J. Matern. Fetal Neonatal Med. 33, 2202\u20132208 (2020).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"977_CR156","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/bcp.13483","volume":"84","author":"K McLaughlin","year":"2018","unstructured":"McLaughlin, K., Scholten, R. R., Parker, J. D., Ferrazzi, E. & Kingdom, J. C. P. Low molecular weight heparin for the prevention of severe preeclampsia: where next? Br. J. Clin. Pharmacol. 84, 673\u2013678 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"977_CR157","doi-asserted-by":"publisher","first-page":"S1126","DOI":"10.1016\/j.ajog.2020.11.006","volume":"226","author":"M Cruz-Lemini","year":"2022","unstructured":"Cruz-Lemini, M., Vazquez, J. C., Ullmo, J. & Llurba, E. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 226, S1126\u2013S1144.e17 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR158","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJMoa2307212","volume":"390","author":"P Dwarkanath","year":"2024","unstructured":"Dwarkanath, P. et al. Two randomized trials of low-dose calcium supplementation in pregnancy. N. Engl. J. Med. 390, 143\u2013153 (2024).","journal-title":"N. Engl. J. Med."},{"key":"977_CR159","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1111\/1471-0528.17222","volume":"129","author":"ML Woo Kinshella","year":"2022","unstructured":"Woo Kinshella, M. L. et al. Calcium for pre-eclampsia prevention: a systematic review and network meta-analysis to guide personalised antenatal care. BJOG 129, 1833\u20131843 (2022).","journal-title":"BJOG"},{"key":"977_CR160","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/ndt\/gfad185","volume":"39","author":"P Evenepoel","year":"2024","unstructured":"Evenepoel, P. et al. Recommended calcium intake in adults and children with chronic kidney disease \u2014 a European consensus statement. Nephrol. Dial. Transpl. 39, 341\u2013366 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1177829","volume":"14","author":"A Aguilar","year":"2023","unstructured":"Aguilar, A. et al. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis. Front. Physiol. 14, 1177829 (2023).","journal-title":"Front. Physiol."},{"key":"977_CR162","unstructured":"World Health Organisation. WHO Recommendation: Calcium Supplementation during Pregnancy for the Prevention of Pre-eclampsia and its Complications (WHO, 2018)."},{"key":"977_CR163","volume":"10","author":"GJ Hofmeyr","year":"2018","unstructured":"Hofmeyr, G. J., Lawrie, T. A., Atallah, A. N. & Torloni, M. R. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst. Rev. 10, CD001059 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"977_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2571-5","volume":"19","author":"B Bhowmik","year":"2019","unstructured":"Bhowmik, B. et al. Maternal BMI and nutritional status in early pregnancy and its impact on neonatal outcomes at birth in Bangladesh. BMC Pregnancy Childbirth 19, 413 (2019).","journal-title":"BMC Pregnancy Childbirth"},{"key":"977_CR165","unstructured":"World Health organization. WHO Antenatal Care Recommendations for a Positive Pregnancy Experience \u2014 Nutritional Interventions Update: Vitamin D Supplements during Pregnancy (WHO, 2020)."},{"key":"977_CR166","volume":"7","author":"C Palacios","year":"2024","unstructured":"Palacios, C., Kostiuk, L. L., Cuthbert, A. & Weeks, J. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst. Rev. 7, CD008873 (2024).","journal-title":"Cochrane Database Syst. Rev."},{"key":"977_CR167","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911\u20131930 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"977_CR168","doi-asserted-by":"publisher","first-page":"d2901","DOI":"10.1136\/bmj.d2901","volume":"342","author":"F Vadillo-Ortega","year":"2011","unstructured":"Vadillo-Ortega, F. et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 342, d2901 (2011).","journal-title":"BMJ"},{"key":"977_CR169","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3390\/jcm13082198","volume":"13","author":"C Taliento","year":"2024","unstructured":"Taliento, C. et al. Effect of physical activity during pregnancy on the risk of hypertension disorders and gestational diabetes: evidence generated by new RCTs and systematic reviews. J. Clin. Med. 13, 2198 (2024).","journal-title":"J. Clin. Med."},{"key":"977_CR170","unstructured":"European Commission. Dietary recommendations for protein intake for pregnant and lactating women. EC https:\/\/knowledge4policy.ec.europa.eu\/health-promotion-knowledge-gateway\/dietary-protein-dietary-intake-pregnant-4_en (2021)."},{"key":"977_CR171","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","volume":"76","author":"TA Ikizler","year":"2020","unstructured":"Ikizler, T. A. et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am. J. Kidney Dis. 76, S1\u2013S107 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"977_CR172","unstructured":"Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids (National Academies, 2005)."},{"key":"977_CR173","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/bmjnph-2021-000399","volume":"5","author":"A Perry","year":"2022","unstructured":"Perry, A., Stephanou, A. & Rayman, M. P. Dietary factors that affect the risk of pre-eclampsia. BMJ Nutr. Prev. Health 5, 118\u2013133 (2022).","journal-title":"BMJ Nutr. Prev. Health"},{"key":"977_CR174","doi-asserted-by":"publisher","first-page":"729S","DOI":"10.1093\/ajcn\/nqy353","volume":"109","author":"R Raghavan","year":"2019","unstructured":"Raghavan, R. et al. Dietary patterns before and during pregnancy and birth outcomes: a systematic review. Am. J. Clin. Nutr. 109, 729S\u2013756S (2019).","journal-title":"Am. J. Clin. Nutr."},{"key":"977_CR175","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3945\/jn.109.104968","volume":"139","author":"AL Brantsaeter","year":"2009","unstructured":"Brantsaeter, A. L. et al. A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women. J. Nutr. 139, 1162\u20131168 (2009).","journal-title":"J. Nutr."},{"key":"977_CR176","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cmet.2019.05.020","volume":"30","author":"KD Hall","year":"2019","unstructured":"Hall, K. D. et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab. 30, 226 (2019).","journal-title":"Cell Metab."},{"key":"977_CR177","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.3390\/nu14194203","volume":"14","author":"R Attini","year":"2022","unstructured":"Attini, R. et al. Plant-based diets improve maternal-fetal outcomes in CKD pregnancies. Nutrients 14, 4203 (2022).","journal-title":"Nutrients"},{"key":"977_CR178","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/ndt\/gfq333","volume":"26","author":"GB Piccoli","year":"2011","unstructured":"Piccoli, G. B. et al. Vegetarian supplemented low-protein diets. A safe option for pregnant CKD patients: report of 12 pregnancies in 11 patients. Nephrol. Dial. Transpl. 26, 196\u2013205 (2011).","journal-title":"Nephrol. Dial. Transpl."},{"key":"977_CR179","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2215\/CJN.06690613","volume":"9","author":"GB Piccoli","year":"2014","unstructured":"Piccoli, G. B. et al. Association of low-protein supplemented diets with fetal growth in pregnant women with CKD. Clin. J. Am. Soc. Nephrol. 9, 864\u2013873 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"977_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-020-01330-0","volume":"20","author":"M Vilar-Compte","year":"2021","unstructured":"Vilar-Compte, M. et al. Urban poverty and nutrition challenges associated with accessibility to a healthy diet: a global systematic literature review. Int. J. Equity Health 20, 40 (2021).","journal-title":"Int. J. Equity Health"},{"key":"977_CR181","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki, A. et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N. Engl. J. Med. 374, 434\u2013443 (2016).","journal-title":"N. Engl. J. Med."},{"key":"977_CR182","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/dme.13523","volume":"35","author":"A Alqudah","year":"2018","unstructured":"Alqudah, A. et al. Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis. Diabet. Med. 35, 160\u2013172 (2018).","journal-title":"Diabet. Med."},{"key":"977_CR183","doi-asserted-by":"publisher","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","volume":"214","author":"MM Costantine","year":"2016","unstructured":"Costantine, M. M. et al. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am. J. Obstet. Gynecol. 214, 720.e1\u2013720.e17 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR184","doi-asserted-by":"publisher","first-page":"666.e1","DOI":"10.1016\/j.ajog.2021.05.018","volume":"225","author":"MM Costantine","year":"2021","unstructured":"Costantine, M. M. et al. A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia. Am. J. Obstet. Gynecol. 225, 666.e1\u2013666.e15 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR185","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1055\/a-1798-1925","volume":"41","author":"MIA Akbar","year":"2024","unstructured":"Akbar, M. I. A. et al. INOVASIA study: a multicenter randomized clinical trial of pravastatin to prevent preeclampsia in high-risk patients. Am. J. Perinatol. 41, 1203\u20131211 (2024).","journal-title":"Am. J. Perinatol."},{"key":"977_CR186","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/1471-0528.16013","volume":"127","author":"A Ahmed","year":"2020","unstructured":"Ahmed, A. et al. Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial. BJOG 127, 478\u2013488 (2020).","journal-title":"BJOG"},{"key":"977_CR187","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.3390\/ijms21134698","volume":"21","author":"MF Rozas-Villanueva","year":"2020","unstructured":"Rozas-Villanueva, M. F., Casanello, P. & Retamal, M. A. Role of ROS\/RNS in preeclampsia: are connexins the missing piece? Int. J. Mol. Sci. 21, 4698 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"977_CR188","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-016-0902-3","volume":"16","author":"FC Brownfoot","year":"2016","unstructured":"Brownfoot, F. C. et al. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta. BMC Pregnancy Childbirth 16, 117 (2016).","journal-title":"BMC Pregnancy Childbirth"},{"key":"977_CR189","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/1471-0528.17393","volume":"130","author":"L Meijerink","year":"2023","unstructured":"Meijerink, L. et al. Statins in pre-eclampsia or fetal growth restriction: a systematic review and meta-analysis on maternal blood pressure and fetal growth across species. BJOG 130, 577\u2013585 (2023).","journal-title":"BJOG"},{"key":"977_CR190","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.mayocp.2022.06.005","volume":"97","author":"A Kattah","year":"2022","unstructured":"Kattah, A. et al. Complement C5 inhibition as a novel therapeutic approach in severe pre-eclampsia. Mayo Clin. Proc. 97, 1580\u20131583 (2022).","journal-title":"Mayo Clin. Proc."},{"key":"977_CR191","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","volume":"124","author":"R Thadhani","year":"2011","unstructured":"Thadhani, R. et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124, 940\u2013950 (2011).","journal-title":"Circulation"},{"key":"977_CR192","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/HYPERTENSIONAHA.109.141937","volume":"55","author":"JS Gilbert","year":"2010","unstructured":"Gilbert, J. S. et al. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placental ischemia-induced hypertension. Hypertension 55, 380\u2013385 (2010).","journal-title":"Hypertension"},{"key":"977_CR193","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ncpneph0991","volume":"5","author":"T Hamano","year":"2009","unstructured":"Hamano, T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat. Clin. Pract. Nephrol. 5, 8\u20139 (2009).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"977_CR194","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s40620-024-02137-w","volume":"37","author":"GB Piccoli","year":"2024","unstructured":"Piccoli, G. B. et al. The ABCs of post-preeclampsia outpatient nephrology care: the Le Mans strategy. J. Nephrol. 37, 2481\u20132489 (2024).","journal-title":"J. Nephrol."},{"key":"977_CR195","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ehjqcco\/qcad065","volume":"10","author":"A Inversetti","year":"2024","unstructured":"Inversetti, A. et al. Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis. Eur. Heart J. Qual. Care Clin. Outcomes 10, 4\u201313 (2024).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"977_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2024.101127","volume":"36","author":"AC Staff","year":"2024","unstructured":"Staff, A. C., Costa, M. L., Dechend, R., Jacobsen, D. P. & Sugulle, M. Hypertensive disorders of pregnancy and long-term maternal cardiovascular risk: bridging epidemiological knowledge into personalized postpartum care and follow-up. Pregnancy Hypertens. 36, 101127 (2024).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR197","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ahj.2024.03.014","volume":"273","author":"MA Daubert","year":"2024","unstructured":"Daubert, M. A. et al. Early postpartum blood pressure screening is associated with increased detection of cardiovascular risk factors in women with hypertensive disorders of pregnancy. Am. Heart J. 273, 130\u2013139 (2024).","journal-title":"Am. Heart J."},{"key":"977_CR198","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024443","volume":"11","author":"CM Ackerman-Banks","year":"2022","unstructured":"Ackerman-Banks, C. M. et al. Seizing the window of opportunity within 1 year postpartum: early cardiovascular screening. J. Am. Heart Assoc. 11, e024443 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"977_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjqcco\/qcad070","volume":"10","author":"F Conti-Ramsden","year":"2024","unstructured":"Conti-Ramsden, F., Bramham, K. & de Marvao, A. Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action. Eur. Heart J. Qual. Care Clin. Outcomes 10, 1\u20133 (2024).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"977_CR200","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.116.003497","volume":"10","author":"P Wu","year":"2017","unstructured":"Wu, P. et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes 10, e003497 (2017).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"977_CR201","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013991","volume":"9","author":"CCW Lo","year":"2020","unstructured":"Lo, C. C. W. et al. Future cardiovascular disease risk for women with gestational hypertension: a systematic review and meta-analysis. J. Am. Heart Assoc. 9, e013991 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"977_CR202","first-page":"108","volume":"25","author":"EK Tannor","year":"2022","unstructured":"Tannor, E. K., Nlandu, Y. M., Elrggal, M. E., Chika, O. U. & Nzana, V. Kidney health for all \u2014 bridging the gap to better kidney care in Africa. Afr. J. Nephrol. 25, 108\u2013115 (2022).","journal-title":"Afr. J. Nephrol."},{"key":"977_CR203","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5830\/CVJA-2018-027","volume":"29","author":"MA Talle","year":"2018","unstructured":"Talle, M. A. et al. Status of cardiac arrhythmia services in Africa in 2018: a PASCAR sudden cardiac death task force report. Cardiovasc. J. Afr. 29, 115\u2013121 (2018).","journal-title":"Cardiovasc. J. Afr."},{"key":"977_CR204","volume":"37","author":"MAA Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves, M. A. A., Morais, H., Oliveira, G. M. M. D. & Mesquita, C. T. Challenges and perspectives for cardiology in the developing world: joint views from Africa and Latin America. Int. J. Cardiovasc. Sci. 37, e20240002 (2024).","journal-title":"Int. J. Cardiovasc. Sci."},{"key":"977_CR205","doi-asserted-by":"crossref","unstructured":"Anumudu, S. J. & Fadem, S. Z. in Nephrology Worldwide (eds Moura-Neto, J. A., Divino-Filho, J. C. & Ronco, C.) 173\u2013186 (Springer, 2021).","DOI":"10.1007\/978-3-030-56890-0_15"},{"key":"977_CR206","doi-asserted-by":"crossref","unstructured":"Bellasi, A. et al. in Nephrology Worldwide (eds Moura-Neto, J. A., Divino-Filho, J. C. & Ronco, C.) 557\u2013568 (Springer, 2021).","DOI":"10.1007\/978-3-030-56890-0_41"},{"key":"977_CR207","unstructured":"European Society of Cardiology. Cardiologists (total) (per million people). ESC https:\/\/eatlas.escardio.org\/Data\/Cardiovascular-healthcare-delivery\/Cardiological-specialists\/chr_card_1m_r-cardiologists-total-per-million-people (2024)."},{"key":"977_CR208","doi-asserted-by":"crossref","unstructured":"Canaud, B. & Choukroun, G. in Nephrology Worldwide (eds Moura-Neto, J. A., Divino-Filho, J. C. & Ronco, C.) 521\u2013541 (Springer, 2021).","DOI":"10.1007\/978-3-030-56890-0_39"},{"key":"977_CR209","unstructured":"European Society of Cardiology. French Society of Cardiology. ESC https:\/\/www.escardio.org\/The-ESC\/Member-National-Cardiac-Societies\/French-Society-of-Cardiology (2024)."},{"key":"977_CR210","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s40620-021-01204-w","volume":"35","author":"C Schulz","year":"2022","unstructured":"Schulz, C. et al. Characteristics of outpatients referred for a first consultation with a nephrologist: impact of different guidelines. J. Nephrol. 35, 1375\u20131385 (2022).","journal-title":"J. Nephrol."},{"key":"977_CR211","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s40620-021-01238-0","volume":"35","author":"S Jesudason","year":"2022","unstructured":"Jesudason, S. Implementing referral systems for nephrology services: real world practice versus guidelines. J. Nephrol. 35, 1369\u20131370 (2022).","journal-title":"J. Nephrol."},{"key":"977_CR212","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/imj.16377","volume":"54","author":"K Li","year":"2024","unstructured":"Li, K. et al. Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology care. Intern. Med. J. 54, 1126\u20131135 (2024).","journal-title":"Intern. Med. J."},{"key":"977_CR213","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473\u2013485 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"977_CR214","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneph.2017.181","volume":"14","author":"JJ Carrero","year":"2018","unstructured":"Carrero, J. J., Hecking, M., Chesnaye, N. C. & Jager, K. J. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat. Rev. Nephrol. 14, 151\u2013164 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"977_CR215","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fbioe.2020.00064","volume":"8","author":"L Li","year":"2020","unstructured":"Li, L. et al. Trophoblast-targeted nanomedicine modulates placental sFLT1 for preeclampsia treatment. Front. Bioeng. Biotechnol. 8, 64 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"977_CR216","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nbt.4297","volume":"36","author":"AA Turanov","year":"2018","unstructured":"Turanov, A. A. et al. RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nat. Biotechnol. 36, 1164\u20131173 (2018).","journal-title":"Nat. Biotechnol."},{"key":"977_CR217","unstructured":"PRNewswire. Comanche Biopharma receives US FDA fast track designation for CBP-4888 for the treatment of sFlt-1 mediated pre-term preeclampsia. PRNewswire https:\/\/www.prnewswire.com\/news-releases\/comanche-biopharma-drug-receives-fda-fast-track-designation-301908285.html (2023)."},{"key":"977_CR218","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.transci.2006.05.010","volume":"35","author":"Y Wang","year":"2006","unstructured":"Wang, Y. et al. Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia. Transfus. Apher. Sci. 35, 103\u2013110 (2006).","journal-title":"Transfus. Apher. Sci."},{"key":"977_CR219","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.preghy.2018.04.007","volume":"12","author":"K Winkler","year":"2018","unstructured":"Winkler, K. et al. Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: the Freiburg preeclampsia H.E.L.P.-apheresis study. Pregnancy Hypertens. 12, 136\u2013143 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"977_CR220","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/jog.12760","volume":"41","author":"B Nakakita","year":"2015","unstructured":"Nakakita, B. et al. Case of soluble fms-like tyrosine kinase 1 apheresis in severe pre-eclampsia developed at 15 weeks\u2019 gestation. J. Obstet. Gynaecol. Res. 41, 1661\u20131663 (2015).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"977_CR221","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5414\/CNP96S18","volume":"96","author":"J Gubensek","year":"2021","unstructured":"Gubensek, J. et al. Treatment of preeclampsia at extremely preterm gestation with therapeutic plasma exchange. Clin. Nephrol. 96, 101\u2013106 (2021).","journal-title":"Clin. Nephrol."},{"key":"977_CR222","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1681\/ASN.2015020157","volume":"27","author":"R Thadhani","year":"2016","unstructured":"Thadhani, R. et al. Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J. Am. Soc. Nephrol. 27, 903\u2013913 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"977_CR223","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejogrb.2018.09.009","volume":"231","author":"B Haddad","year":"2018","unstructured":"Haddad, B. et al. LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: report of two cases from a discontinued phase II trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 231, 70\u201374 (2018).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"977_CR224","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007216","volume":"6","author":"OC Logue","year":"2017","unstructured":"Logue, O. C., Mahdi, F., Chapman, H., George, E. M. & Bidwell, G. L. 3rd A maternally sequestered, biopolymer-stabilized vascular endothelial growth factor (VEGF) chimera for treatment of preeclampsia. J. Am. Heart Assoc. 6, e007216 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"977_CR225","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/HYPERTENSIONAHA.121.17713","volume":"78","author":"JP Waller","year":"2021","unstructured":"Waller, J. P., Howell, J. A., Peterson, H., George, E. M. & Bidwell, G. L. 3rd Elastin-like polypeptide: VEGF-B fusion protein for treatment of preeclampsia. Hypertension 78, 1888\u20131901 (2021).","journal-title":"Hypertension"},{"key":"977_CR226","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1159\/000511260","volume":"51","author":"JE Engel","year":"2020","unstructured":"Engel, J. E. et al. Recovery of renal function following kidney-specific VEGF therapy in experimental renovascular disease. Am. J. Nephrol. 51, 891\u2013902 (2020).","journal-title":"Am. J. Nephrol."},{"key":"977_CR227","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271560","volume":"17","author":"E Kadife","year":"2022","unstructured":"Kadife, E. et al. Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro. PLoS ONE 17, e0271560 (2022).","journal-title":"PLoS ONE"},{"key":"977_CR228","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bcp.14131","volume":"86","author":"C de Moreuil","year":"2020","unstructured":"de Moreuil, C., Alavi, Z. & Pasquier, E. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage. Br. J. Clin. Pharmacol. 86, 39\u201349 (2020).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"977_CR229","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.3389\/fimmu.2019.03098","volume":"10","author":"E Pierik","year":"2019","unstructured":"Pierik, E. et al. Dysregulation of complement activation and placental dysfunction: a potential target to treat preeclampsia? Front. Immunol. 10, 3098 (2019).","journal-title":"Front. Immunol."},{"key":"977_CR230","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.ekir.2020.09.045","volume":"5","author":"E Morales","year":"2020","unstructured":"Morales, E. et al. Eculizumab in early-stage pregnancy. Kidney Int. Rep. 5, 2383\u20132387 (2020).","journal-title":"Kidney Int. Rep."},{"key":"977_CR231","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14767050600587983","volume":"19","author":"I Neri","year":"2006","unstructured":"Neri, I., Jasonni, V. M., Gori, G. F., Blasi, I. & Facchinetti, F. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J. Matern. Fetal Neonatal Med. 19, 277\u2013281 (2006).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"977_CR232","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ajcnut.2024.12.001","volume":"121","author":"N Winer","year":"2025","unstructured":"Winer, N. et al. Oral citrulline supplementation in pregnancies with preeclampsia: a multicenter, randomized, double-blind clinical trial. Am. J. Clin. Nutr. 121, 488\u2013496 (2025).","journal-title":"Am. J. Clin. Nutr."},{"key":"977_CR233","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.117.09741","volume":"70","author":"L Saleh","year":"2017","unstructured":"Saleh, L. et al. Low soluble Fms-like tyrosine kinase-1, endoglin, and endothelin-1 levels in women with confirmed or suspected preeclampsia using proton pump inhibitors. Hypertension 70, 594\u2013600 (2017).","journal-title":"Hypertension"},{"key":"977_CR234","doi-asserted-by":"publisher","first-page":"388.e1","DOI":"10.1016\/j.ajog.2018.07.019","volume":"219","author":"CA Cluver","year":"2018","unstructured":"Cluver, C. A. et al. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial. Am. J. Obstet. Gynecol. 219, 388.e1\u2013388.e17 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR235","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1055\/s-2004-815632","volume":"29","author":"T Kobayashi","year":"2003","unstructured":"Kobayashi, T. et al. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study. Semin. Thromb. Hemost. 29, 645\u2013652 (2003).","journal-title":"Semin. Thromb. Hemost."},{"key":"977_CR236","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1055\/s-0037-1614071","volume":"84","author":"M Maki","year":"2000","unstructured":"Maki, M. et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 study group. Thromb. Haemost. 84, 583\u2013590 (2000).","journal-title":"Thromb. Haemost."},{"key":"977_CR237","doi-asserted-by":"publisher","first-page":"739.e1","DOI":"10.1016\/j.ajog.2020.08.004","volume":"223","author":"MJ Paidas","year":"2020","unstructured":"Paidas, M. J. et al. Prospective, randomized, double-blind, placebo-controlled evaluation of the pharmacokinetics, safety and efficacy of recombinant antithrombin versus placebo in preterm preeclampsia. Am. J. Obstet. Gynecol. 223, 739.e1\u2013739.e13 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"977_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-06218-9","volume":"24","author":"J Chen","year":"2024","unstructured":"Chen, J., Huai, J. & Yang, H. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis. BMC Pregnancy Childbirth 24, 68 (2024).","journal-title":"BMC Pregnancy Childbirth"},{"key":"977_CR239","doi-asserted-by":"publisher","first-page":"12743","DOI":"10.3390\/ijms241612743","volume":"24","author":"MW Socha","year":"2023","unstructured":"Socha, M. W., Chmielewski, J., Pietrus, M. & Wartega, M. Endogenous digitalis-like factors as a key molecule in the pathophysiology of pregnancy-induced hypertension and a potential therapeutic target in preeclampsia. Int. J. Mol. Sci. 24, 12743 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"977_CR240","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/S0140-6736(24)00550-6","volume":"403","author":"GBD 2021 Fertility and Forecasting Collaborators.","year":"2024","unstructured":"GBD 2021 Fertility and Forecasting Collaborators. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global burden of disease study 2021. Lancet 403, 2057\u20132099 (2024).","journal-title":"Lancet"},{"key":"977_CR241","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/1471-0528.15394","volume":"125","author":"L Brouwers","year":"2018","unstructured":"Brouwers, L. et al. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG 125, 1642\u20131654 (2018).","journal-title":"BJOG"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00977-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00977-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00977-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T12:03:42Z","timestamp":1758110622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00977-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":241,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["977"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-00977-8","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"6 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}